Auro Laboratories [ARL] vs Bombay Dyeing [BOMDYEING] Detailed Stock Comparison
Auro Laboratories
BSE
Loading...
Bombay Dyeing
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Auro Laboratories wins in 4 metrics, Bombay Dyeing wins in 14 metrics, with 0 ties. Bombay Dyeing appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Auro Laboratories | Bombay Dyeing | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 208.52 | 7.51 | Bombay Dyeing |
| Price-to-Book Ratio | 10.49 | 1.55 | Bombay Dyeing |
| Debt-to-Equity Ratio | 20.95 | 0.13 | Bombay Dyeing |
| PEG Ratio | 3.48 | -0.70 | Bombay Dyeing |
| EV/EBITDA | 118.12 | -58.22 | Bombay Dyeing |
| Profit Margin (TTM) | 1.29% | 31.88% | Bombay Dyeing |
| Operating Margin (TTM) | 1.38% | -5.79% | Auro Laboratories |
| EBITDA Margin (TTM) | 1.38% | N/A | N/A |
| Return on Equity | 4.52% | 20.91% | Bombay Dyeing |
| Return on Assets (TTM) | 3.51% | 16.36% | Bombay Dyeing |
| Free Cash Flow (TTM) | $104.35M | $-727.10M | Auro Laboratories |
| Dividend Yield | N/A | 1.45% | N/A |
| 1-Year Return | 790.49% | -19.59% | Auro Laboratories |
| Price-to-Sales Ratio (TTM) | 2.92 | 2.39 | Bombay Dyeing |
| Enterprise Value | $9.13B | $30.40B | Bombay Dyeing |
| EV/Revenue Ratio | 2.86 | 1.98 | Bombay Dyeing |
| Gross Profit Margin (TTM) | 3.47% | 22.64% | Bombay Dyeing |
| Revenue per Share (TTM) | $161 | $74 | Auro Laboratories |
| Earnings per Share (Diluted) | $2.10 | $23.64 | Bombay Dyeing |
| Beta (Stock Volatility) | 0.09 | 0.00 | Bombay Dyeing |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Auro Laboratories vs Bombay Dyeing Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Auro Laboratories | 1.01% | 4.89% | 19.08% | 51.79% | 113.62% | 189.25% |
| Bombay Dyeing | -2.36% | 7.45% | -0.03% | 8.23% | 42.85% | -9.14% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Auro Laboratories | 790.49% | 675.55% | 1,372.64% | 1,287.50% | 1,287.50% | 1,287.50% |
| Bombay Dyeing | -19.59% | 83.05% | 169.30% | 156.48% | 40.74% | 149.49% |
News Based Sentiment: Auro Laboratories vs Bombay Dyeing
Auro Laboratories
News based Sentiment: NEUTRAL
The month saw minor positive developments – a slight share price increase and growing shareholding – coupled with standard corporate governance procedures. These events don't represent a major shift in the investment story, but indicate continued stability and preparation for upcoming financial results.
Bombay Dyeing
News based Sentiment: MIXED
Bombay Dyeing's month was marked by both positive developments – becoming debt-free through substantial land sales – and concerning trends, like declining total income in Q2 2025. The leadership change and ongoing real estate projects add further complexity to the investment picture, making it a mixed story overall.
Performance & Financial Health Analysis: Auro Laboratories vs Bombay Dyeing
| Metric | ARL | BOMDYEING |
|---|---|---|
| Market Information | ||
| Market Cap | ₹9.33B | ₹36.69B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 22,660 | 1,004,822 |
| 90 Day Avg. Volume | 19,847 | 1,571,574 |
| Last Close | ₹448.50 | ₹173.55 |
| 52 Week Range | ₹147.55 - ₹450.00 | ₹117.50 - ₹256.40 |
| % from 52W High | -0.33% | -32.31% |
| All-Time High | ₹450.00 (Oct 07, 2025) | ₹321.90 (May 07, 2018) |
| % from All-Time High | -0.33% | -46.09% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | -0.16% |
| Quarterly Earnings Growth | 1.25% | -0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.32% |
| Operating Margin (TTM) | 0.01% | -0.06% |
| Return on Equity (TTM) | 0.05% | 0.21% |
| Debt to Equity (MRQ) | 20.95 | 0.13 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹41.76 | ₹114.77 |
| Cash per Share (MRQ) | ₹11.25 | ₹29.21 |
| Operating Cash Flow (TTM) | ₹151.50M | ₹6.23B |
| Levered Free Cash Flow (TTM) | ₹34.72M | ₹4.90B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.45% |
| Last 12-Month Dividend | N/A | ₹2.40 |
Valuation & Enterprise Metrics Analysis: Auro Laboratories vs Bombay Dyeing
| Metric | ARL | BOMDYEING |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 208.52 | 7.51 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 3.48 | -0.70 |
| Price to Sales (TTM) | 2.92 | 2.39 |
| Price to Book (MRQ) | 10.49 | 1.55 |
| Market Capitalization | ||
| Market Capitalization | ₹9.33B | ₹36.69B |
| Enterprise Value | ₹9.13B | ₹30.40B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.86 | 1.98 |
| Enterprise to EBITDA | 118.12 | -58.22 |
| Risk & Other Metrics | ||
| Beta | 0.09 | 0.00 |
| Book Value per Share (MRQ) | ₹41.76 | ₹114.77 |
Financial Statements Comparison: Auro Laboratories vs Bombay Dyeing
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ARL | BOMDYEING |
|---|---|---|
| Revenue/Sales | ₹759.54M | ₹3.78B |
| Cost of Goods Sold | ₹733.20M | ₹2.92B |
| Gross Profit | ₹26.34M | ₹855.40M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹10.50M | ₹-218.80M |
| EBITDA | ₹14.47M | ₹226.90M |
| Pre-Tax Income | ₹11.77M | ₹111.40M |
| Income Tax | ₹0 | ₹-26.70M |
| Net Income (Profit) | ₹11.77M | ₹138.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ARL | BOMDYEING |
|---|---|---|
| Cash & Equivalents | ₹236.38M | ₹331.50M |
| Total Current Assets | ₹965.77M | ₹12.91B |
| Total Current Liabilities | ₹180.31M | ₹5.25B |
| Long-Term Debt | ₹39.88M | ₹29.40M |
| Total Shareholders Equity | ₹768.87M | ₹23.44B |
| Retained Earnings | N/A | ₹16.04B |
| Property, Plant & Equipment | ₹0 | ₹5.79B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ARL | BOMDYEING |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ARL | BOMDYEING |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 22,660 | 1,004,822 |
| Average Daily Volume (90 Day) | 19,847 | 1,571,574 |
| Shares Outstanding | 18.38M | 206.53M |
| Float Shares | 9.13M | 87.56M |
| % Held by Insiders | 0.55% | 0.56% |
| % Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Auro Laboratories vs Bombay Dyeing
| Metric | ARL | BOMDYEING |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹2.40 |
| Last 12-Month Dividend Yield | N/A | 1.45% |
| 3-Year Avg Annual Dividend | N/A | ₹0.80 |
| 3-Year Avg Dividend Yield | N/A | 0.64% |
| 3-Year Total Dividends | N/A | ₹2.40 |
| Ex-Dividend Date | N/A | Aug 06, 2025 |